Simple blood test may predict how badly back pain affects your life

NCT ID NCT07664904

Recruiting now Knowledge-focused Sponsor: Keimyung University Dongsan Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times

Summary

This study will check if a protein called periostin in the blood is related to how much back pain limits daily activities and quality of life. Researchers will measure periostin in 38 adults with lumbar disc problems and compare it to their scores on disability and health questionnaires. The goal is to see if a blood test could help assess disease severity.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors use a simple blood test to measure how severely a person's spinal disc disease affects their daily function and well-being.
What could go wrong: This is a very small, early observational study (38 people) that only looks for a link, not a treatment. The results may not apply to everyone with disc disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTERVERTEBRAL DISC DEGENERATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

intervertebral disk degenerative disorder lumbar disk degenerative disorder lumbar disk herniation, susceptibility to lumbar spinal stenosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INTERVERTEBRAL DISC DISEASE

Contacts and locations

Locations

Hong Ji Hee
RECRUITING

Daegu, South Korea
Ji Hee
RECRUITING

Daegu, Daegu, 42601, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.